Ranbaxy Laboratories
Ranbaxy Laboratories Limited was an Indian multinational pharmaceutical company that was incorporated in India in 1961 and remained an entity until 2014. The company went public in 1973. Ownership of Ranbaxy changed twice over the course of its history.
| Company type | Subsidiary |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 1961 |
| Founders | Ranbir Singh Gurbax Singh |
| Defunct | 2014 |
| Fate | Acquired by Sun Pharma |
| Successor | Sun Pharmaceuticals |
| Headquarters | , |
Key people |
|
Number of employees | 10,983 (2012) |
| Parent | Sun Pharmaceuticals |
In 2008, Japanese pharmaceutical company Daiichi Sankyo acquired a controlling share in Ranbaxy and in 2014, Sun Pharma acquired 100% of Ranbaxy in an all-stock deal. The Sun Pharma acquisition brought all new management to Ranbaxy, which had been laden with controversy (see Controversies below). Sun is the world's fifth largest specialty generic pharmaceutical company.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.